BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23868550)

  • 1. Impact of the HPV-positivity definition on the prognostic value of HPV status in patients with locally advanced squamous cell carcinoma of the head and neck.
    Rades D; Seibold ND; Hoffmann A; Gebhard MP; Noack F; Thorns C; Schild SE
    Strahlenther Onkol; 2013 Oct; 189(10):856-60. PubMed ID: 23868550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of VEGF and FLT-1 receptor expression in patients with locally advanced squamous cell carcinoma of the head and neck.
    Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F; Rades D
    Strahlenther Onkol; 2013 Aug; 189(8):639-46. PubMed ID: 23748230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the prognostic role of tumor cell podoplanin expression in locally advanced squamous cell carcinoma of the head and neck.
    Huttenlocher S; Seibold ND; Gebhard MP; Noack F; Thorns C; Hasselbacher K; Wollenberg B; Schild SE; Rades D
    Strahlenther Onkol; 2014 Oct; 190(11):1021-7. PubMed ID: 24928249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential impact of human papilloma virus on survival of basaloid squamous carcinoma of the head and neck.
    Jacobi C; Ayx I; Fritsche K; Piontek G; Hoffmann D; Weirich G; Knopf A
    Oncotarget; 2015 Feb; 6(5):3462-70. PubMed ID: 25739121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 2 is of prognostic value for patients with locally advanced squamous cell carcinoma of the head and neck.
    Rades D; Seibold ND; Gebhard MP; Noack F; Bruchhage KL; Schild SE
    Strahlenther Onkol; 2014 Jan; 190(1):68-74. PubMed ID: 23861152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor expression: prognostic value in locally advanced squamous cell carcinoma of the head and neck.
    Rades D; Seibold ND; Schild SE; Bruchhage KL; Gebhard MP; Noack F
    Strahlenther Onkol; 2013 Oct; 189(10):849-55. PubMed ID: 23959264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of p16 immunohistochemistry and increased sensitivity of RNA in situ hybridization in cytology specimens of HPV-related head and neck squamous cell carcinoma.
    Wong KS; Krane JF; Jo VY
    Cancer Cytopathol; 2019 Oct; 127(10):632-642. PubMed ID: 31509355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus.
    Mehrad M; Carpenter DH; Chernock RD; Wang H; Ma XJ; Luo Y; Luo J; Lewis JS; El-Mofty SK
    Am J Surg Pathol; 2013 Sep; 37(9):1349-56. PubMed ID: 23797720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of HPV-status on survival of patients with tonsillar carcinomas (TSCC) treated by CO
    Hoffmann M; Quabius ES; Tribius S; Gebhardt S; Görögh T; Hedderich J; Huber K; Dunst J; Ambrosch P
    Cancer Lett; 2018 Jan; 413():59-68. PubMed ID: 29100961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Rades D; Seibold ND; Gebhard MP; Noack F; Schild SE; Thorns C
    Strahlenther Onkol; 2011 Oct; 187(10):626-32. PubMed ID: 21932027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fidelity of p16 Staining as a Surrogate Marker of Human Papillomavirus Status in Fine-Needle Aspirates and Core Biopsies of Neck Node Metastases: Implications for HPV Testing Protocols.
    Holmes BJ; Maleki Z; Westra WH
    Acta Cytol; 2015; 59(1):97-103. PubMed ID: 25765380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV Infection and Anemia Status Stratify the Survival of Early T2 Laryngeal Squamous Cell Carcinoma.
    Wang H; Zhang Z; Sun R; Lin H; Gong L; Fang M; Hu WH
    J Voice; 2015 May; 29(3):356-62. PubMed ID: 25484261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16-positive lymph node metastases from cutaneous head and neck squamous cell carcinoma: No association with high-risk human papillomavirus or prognosis and implications for the workup of the unknown primary.
    McDowell LJ; Young RJ; Johnston ML; Tan TJ; Kleid S; Liu CS; Bressel M; Estall V; Rischin D; Solomon B; Corry J
    Cancer; 2016 Apr; 122(8):1201-8. PubMed ID: 26881928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
    Xu B; Ghossein R; Lane J; Lin O; Katabi N
    Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
    Vermorken JB; Psyrri A; Mesía R; Peyrade F; Beier F; de Blas B; Celik I; Licitra L
    Ann Oncol; 2014 Apr; 25(4):801-807. PubMed ID: 24577117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor prognostic factors in human papillomavirus-positive head and neck cancer: who might not be candidates for de-escalation treatment?
    Yoo SH; Ock CY; Keam B; Park SJ; Kim TM; Kim JH; Jeon YK; Chung EJ; Kwon SK; Hah JH; Kwon TK; Jung KC; Kim DW; Wu HG; Sung MW; Heo DS
    Korean J Intern Med; 2019 Nov; 34(6):1313-1323. PubMed ID: 30428646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
    Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
    Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.